While [11C]PBB3 appeared to preferentially bind to tau deposits with a close spatial relationship to Aβ, the binding pattern of [11C]THK5351 fitted the expected distribution of tau pathology in Alzheimer’s disease better and was more closely related to downstream disease markers [46]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.